サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1807189

胸部大動脈瘤市場- 世界の産業規模、シェア、動向、機会、予測、治療別、最終用途別、地域別、競合別、2020-2030年

Thoracic Aortic Aneurysm Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment, By End Use, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 185 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.98円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

胸部大動脈瘤市場- 世界の産業規模、シェア、動向、機会、予測、治療別、最終用途別、地域別、競合別、2020-2030年
出版日: 2025年08月31日
発行: TechSci Research
ページ情報: 英文 185 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の胸部大動脈瘤市場は、2024年に32億8,000万米ドルと評価され、2030年にはCAGR 4.77％で76億1,000万米ドルに達すると予測されています。

この背景には、心血管疾患の有病率の増加、診断技術の進歩、早期発見・治療に対する意識の高まりがあります。胸部大動脈瘤は、胸部の大動脈の異常な膨らみを特徴とし、放置すると生命を脅かす破裂を含む重大な健康リスクをもたらします。

市場概要
予測期間 2026-2030
市場規模：2024年 32億8,000万米ドル
市場規模：2030年 76億1,000万米ドル
CAGR：2025年～2030年 4.77%
急成長セグメント オープンサージカルリペア（OSR）
最大市場 北米

血管内動脈瘤修復術（EVAR）など、従来の開腹手術に比べてより安全で効果的な治療法を提供する低侵襲手術手技の技術革新が市場の拡大を支えています。主な課題としては、高度な外科手術やデバイスのコストが高いこと、特定の地域では専門ヘルスケア施設へのアクセスが限られていることなどが挙げられ、市場浸透を制限する可能性があります。

主な市場促進要因

ヘルスケア産業の成長

主な市場課題

診断の遅れと無症候性

主な市場動向

先進医療と個別化治療

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界の胸部大動脈瘤市場に与える影響

第5章 世界の胸部大動脈瘤市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 治療（開胸手術（OSR）、胸部血管内瘤修復術（TEVAR）、ハイブリッド手術、分岐血管内瘤修復術（BEVAR）、その他）
    • 用途別（病院、外来手術センター（ASC）、診療所、その他）
    • 地域別
    • 企業別（2024）
  • 市場マップ

第6章 北米の胸部大動脈瘤市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州の胸部大動脈瘤市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の胸部大動脈瘤市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米の胸部大動脈瘤市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの胸部大動脈瘤市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併と買収
  • 製品上市
  • 最近の動向

第13章 混乱：紛争、パンデミック、貿易障壁

第14章 世界の胸部大動脈瘤市場：SWOT分析

第15章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第16章 競合情勢

  • Medtronic plc
  • W.L. Gore & Associates, Inc.
  • Cook Medical Inc.
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • Boston Scientific Corporation
  • Artivion Inc.
  • Cardiatis S.A.
  • Endologix Inc.
  • Braile Biomedica

第17章 戦略的提言

第18章 調査会社について・免責事項

目次
Product Code: 30528

Global Thoracic Aortic Aneurysm Market was valued at USD 3.28 Billion in 2024 and is expected to reach USD 7.61 Billion by 2030 with a CAGR of 4.77%. This is driven by increasing prevalence of cardiovascular diseases, advances in diagnostic technologies, and rising awareness about early detection and treatment. Thoracic aortic aneurysm, characterized by the abnormal bulging of the aorta in the chest region, poses significant health risks including life-threatening ruptures if left untreated.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.28 Billion
Market Size 2030USD 7.61 Billion
CAGR 2025-20304.77%
Fastest Growing SegmentOpen Surgical Repair (OSR)
Largest MarketNorth America

Market expansion is supported by technological innovations in minimally invasive surgical techniques, such as endovascular aneurysm repair (EVAR), which offer safer and more effective treatment options compared to traditional open surgery. Key challenges include the high cost of advanced surgical procedures and devices, as well as limited accessibility to specialized healthcare facilities in certain regions, which may restrict market penetration.

Key Market Drivers

Growth in Healthcare Industry

The rapid growth of the global healthcare industry is a significant driver propelling the expansion of the thoracic aortic aneurysm (TAA) market. The global healthcare industry generates annual sales exceeding USD 4 trillion. The largest and most lucrative segments are pharmaceuticals and biotechnology, accounting for nearly USD 850 billion, and medical technology and diagnostics, which exceed USD 400 billion in revenue. Increased healthcare expenditure, advancements in diagnostic technologies, and the rising prevalence of cardiovascular diseases are collectively fueling demand for effective TAA detection and treatment solutions worldwide.

As healthcare infrastructure improves globally, more patients are gaining access to specialized cardiovascular care, leading to higher diagnosis rates and increased adoption of surgical and minimally invasive interventions for thoracic aortic aneurysms. The PEN-Plus strategy decentralizes specialized cardiovascular care to district hospitals by reallocating responsibilities to multidisciplinary teams of midlevel professionals. It aims to ensure sustainability by enhancing health literacy to encourage self-management, leveraging community health workers to improve patient retention, engaging peer-support groups, and establishing clear referral and counter-referral pathways for patients with cardiovascular disease (CVD). Furthermore, growing awareness about cardiovascular health and early screening initiatives are contributing to market growth.

Key Market Challenges

Late Diagnosis and Asymptomatic Nature

One of the primary challenges confronting the global thoracic aortic aneurysm market is the condition's asymptomatic nature, which often leads to late diagnosis. Many patients with thoracic aortic aneurysms remain unaware of their condition until symptoms manifest in advanced stages or until life-threatening complications, such as aortic rupture or dissection, occur. This silent progression significantly complicates timely intervention and treatment.

The lack of early, noticeable symptoms poses a major barrier for healthcare providers in identifying at-risk individuals before critical damage occurs. Consequently, patients frequently present with the disease at a stage when therapeutic options are more complex, invasive, and associated with higher risks. Moreover, limited awareness among the general population and inadequate routine screening protocols contribute to delayed detection.

Key Market Trends

Advanced Clinical Practices and Personalized Treatment

The adoption of advanced clinical practices and personalized treatment approaches is a key trend shaping the global thoracic aortic aneurysm (TAA) market. Open-chest thoracic aortic aneurysm repair continues to be the standard surgical treatment for thoracic aortic aneurysms (TAAs), representing the established approach for managing this condition. This procedure remains the preferred method due to its proven effectiveness in addressing complex aneurysms within the thoracic aorta. Innovations in diagnostic imaging, genetic profiling, and minimally invasive surgical techniques are enabling healthcare providers to tailor interventions more precisely to individual patient needs.

Personalized treatment strategies, supported by enhanced risk assessment tools and patient-specific data, are improving the accuracy of aneurysm detection, monitoring, and management. This approach reduces complications, optimizes therapeutic outcomes, and enhances patient quality of life. Moreover, the integration of multidisciplinary care teams and the use of advanced endovascular devices reflect a broader shift towards precision medicine in TAA treatment.

Key Market Players

  • Medtronic plc
  • W.L. Gore & Associates, Inc.
  • Cook Medical Inc.
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • Boston Scientific Corporation
  • Artivion Inc.
  • Cardiatis S.A.
  • Endologix Inc.
  • Braile Biomedica

Report Scope

In this report, the Global Thoracic Aortic Aneurysm Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Thoracic Aortic Aneurysm Market, By Treatment:

  • Open Surgical Repair (OSR)
  • Thoracic Endovascular Aneurysm Repair (TEVAR)
  • Hybrid Procedures
  • Branched Endovascular Aneurysm Repair (BEVAR)
  • Others

Thoracic Aortic Aneurysm Market, By End Use:

  • Hospitals
  • Ambulatory surgery centers (ASC)
  • Clinics
  • Others

Thoracic Aortic Aneurysm Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Thoracic Aortic Aneurysm Market.

Available Customizations:

Global Thoracic Aortic Aneurysm Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Thoracic Aortic Aneurysm Market

5. Global Thoracic Aortic Aneurysm Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Treatment (Open Surgical Repair (OSR), Thoracic Endovascular Aneurysm Repair (TEVAR), Hybrid Procedures, Branched Endovascular Aneurysm Repair (BEVAR), Others)
    • 5.2.2. By End Use (Hospitals, Ambulatory surgery centers (ASC), Clinics, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Thoracic Aortic Aneurysm Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Treatment
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Thoracic Aortic Aneurysm Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Treatment
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Thoracic Aortic Aneurysm Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Treatment
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Thoracic Aortic Aneurysm Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Treatment
        • 6.3.3.2.2. By End Use

7. Europe Thoracic Aortic Aneurysm Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Treatment
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Thoracic Aortic Aneurysm Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Treatment
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Thoracic Aortic Aneurysm Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Treatment
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Thoracic Aortic Aneurysm Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Treatment
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Thoracic Aortic Aneurysm Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Treatment
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Thoracic Aortic Aneurysm Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Treatment
        • 7.3.5.2.2. By End Use

8. Asia Pacific Thoracic Aortic Aneurysm Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Treatment
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Thoracic Aortic Aneurysm Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Treatment
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Thoracic Aortic Aneurysm Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Treatment
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Thoracic Aortic Aneurysm Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Treatment
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Thoracic Aortic Aneurysm Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Treatment
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Thoracic Aortic Aneurysm Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Treatment
        • 8.3.5.2.2. By End Use

9. South America Thoracic Aortic Aneurysm Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Treatment
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Thoracic Aortic Aneurysm Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Treatment
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Thoracic Aortic Aneurysm Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Treatment
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Thoracic Aortic Aneurysm Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Treatment
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Thoracic Aortic Aneurysm Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Treatment
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Thoracic Aortic Aneurysm Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Treatment
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Thoracic Aortic Aneurysm Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Treatment
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Thoracic Aortic Aneurysm Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Treatment
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Global Thoracic Aortic Aneurysm Market: SWOT Analysis

15. Porters Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. Medtronic plc
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. W.L. Gore & Associates, Inc.
  • 16.3. Cook Medical Inc.
  • 16.4. Terumo Corporation
  • 16.5. MicroPort Scientific Corporation
  • 16.6. Boston Scientific Corporation
  • 16.7. Artivion Inc.
  • 16.8. Cardiatis S.A.
  • 16.9. Endologix Inc.
  • 16.10. Braile Biomedica

17. Strategic Recommendations

18. About Us & Disclaimer